Cargando…
Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
AIMS: Attention Deficit Hyperactivity Disorder (ADHD) is a behavior disorder originating in childhood comprising of a constellation of features including inattention, impulsivity, and hyperactivity. The National Institute of Clinical Excellence (NICE) Guidelines 2018 recommends methylphenidate as a...
Autores principales: | Cassar, Fabrizia, Grech, Giovanni, Grech, Bertha, Cassar, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772188/ http://dx.doi.org/10.1192/bjo.2021.226 |
Ejemplares similares
-
Reasonable adjustments for autistic adults
por: Hashmi, Nazish, et al.
Publicado: (2021) -
Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
por: Ekinci, Ozalp, et al.
Publicado: (2020) -
Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015) -
Cardiac illustrations
por: Grech, V, et al.
Publicado: (1999) -
Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
por: Bro, Søren Pauli, et al.
Publicado: (2015)